Microsampling-based metabolic phenotyping: Innovations and enhanced techniques for comprehensive lipid and lipoprotein profiling

Discover how capillary blood microsamples can enable detailed lipid and lipoprotein profiling, supporting future at-home metabolic health monitoring.

This webinar discusses research exploring the use of finger-prick blood samples as a simple and less invasive alternative to standard blood collection, how the microsamples provide results equivalent to venous blood for lipoproteins and inflammation markers, and a method to analyze over 400 lipids from dried blood spot samples, exemplified through a case study into a diabetic cohort, supporting future at-home metabolic health monitoring.

Of interest to researchers in metabolomics and lipidomics, and clinicians and diabetes educators interested in patient-centric blood collections.

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

I agree for my registration data to be transferred to the lead partner organization (PCSIG).

Date and time

Tuesday

February

16:00 GMT

What you will learn:

Key analytical considerations for successful implementation of microsamples for lipid and lipoprotein profiling
Insights from applying DBS and capillary workflows in a diabetic cohort
Evidence that capillary microsamples can give equivalent results to venous blood for lipoproteins

Speaker:

Jayden Lee Roberts
Lecturer, University of Notre Dame Australia; Australian National Phenome Centre, Murdoch University

Jayden completed his PhD at the Australian National Phenome Centre (ANPC), Murdoch University and lectures at the University of Notre Dame Australia. His research centers on sample miniaturization in metabolic phenotyping, with specific focus on dried blood spot (DBS) microsamples. Jayden aims to make metabolic profiling more patient-centric and accessible, particularly for underserved populations in remote or resource-limited settings, where traditional blood sampling methods often create significant barriers due to logistical challenges and limited healthcare access. He employs a combination of targeted and untargeted LC-MS (TQ, timsTOF) and proton NMR spectroscopy in his analyses. Jayden is also the secretary of the Early Career Member Network (EMN) of the Metabolomics Society and a member of the ANZMetSoc ECR subcommittee.

Moderated by:

Neil Spooner
Founder, Patient Centric Sampling Interest Group

Located in Hertford, UK, Neil is the Chair and co-founder of the PCSIG. He also runs a consultancy company where one of the main drivers is to help Clients understand the benefits of patient centric blood sampling, develop appropriate technologies and workflows and implement them for the benefit of human wellbeing. Neil’s interest in these technologies began in 2007 whilst leading efforts at GlaxoSmithKline to find blood sampling and analysis approaches suitable for the measurement of pharmaceutical concentrations in samples obtained from children.

Share this webinar